WallStreetZenWallStreetZen

NASDAQ: TRIB
Trinity Biotech Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Trinity Biotech revenue was $61.56M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $15.9M, up 4.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TRIB annual revenue was $61.6M, with 8.3% growth year-over-year.

TRIB past revenue growth

How has TRIB's revenue growth performed historically?

Company
8.31%
Industry
4.49%
Market
34.96%
TRIB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TRIB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TRIB's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TRIB revenue history

Current Revenue
$61.6M
Current Earnings
-$31.8M
Current Profit Margin
-51.6%

Be the first to know when TRIB announces revenue.

TRIB Revenue History By Year

TRIB Yearly RevenueTRIB RevenueTRIB ChangeTRIB Revenue Growth
2024-12-31$61.56M$4.72M+8.31%
2023-12-31$56.83M-$5.69M-9.10%
2022-12-31$62.52M-$18.63M-22.96%
2021-12-31$81.15M-$20.83M-20.43%
2020-12-31$101.98M$11.55M+12.77%
2019-12-31$90.44M-$6.60M-6.80%
2018-12-31$97.04M-$2.11M-2.12%
2017-12-31$99.14M-$471.00k-0.47%
2016-12-31$99.61M-$584.00k-0.58%
2015-12-31$100.20M-$4.68M-4.46%
2014-12-31$104.87M$13.66M+14.97%
2013-12-31$91.22M$8.71M+10.55%
2012-12-31$82.51M$4.56M+5.85%
2011-12-31$77.95M-$11.69M-13.04%
2010-12-31$89.64M-$36.27M-28.81%
2009-12-31$125.91M-$14.23M-10.16%
2008-12-31$140.14M-$3.48M-2.42%
2007-12-31$143.62M$24.94M+21.02%
2006-12-31$118.67M$20.11M+20.41%
2005-12-31$98.56M$18.55M+23.19%
2004-12-31$80.01M$14.33M+21.82%
2003-12-31$65.68M$13.70M+26.35%
2002-12-31$51.98MN/AN/A

1 of 2

Trinity Biotech Revenue FAQ

What was TRIB's revenue last quarter?

Trinity Biotech (NASDAQ: TRIB) reported Q4 2024 revenue of $15.86 million up 18.09% year over year. In the same quarter last year, Trinity Biotech's revenue was $13.43 million.

What was Trinity Biotech's revenue in 2024?

Trinity Biotech's annual revenue for the twelve months ending Dec 31, 2024 was $61.56 million, a 8.31% increase year over year.

How much does Trinity Biotech make in a day?

Based on Trinity Biotech annual revenue for the past five years, TRIB makes an average of $199,472.33 per day.

What was Trinity Biotech's annual revenue growth in the past year?

As of Q2 2025, Trinity Biotech's revenue has grown 8.31% year over year. This is 3.82 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 4.49%. Trinity Biotech's revenue in the past year totaled $61.56 million.

How much does Trinity Biotech make in a year?

Trinity Biotech's revenue by year for the past five years is:
  • Trinity Biotech's revenue for the twelve months ending Dec 31, 2024 was $61.56 million, a 8.31% increase year over year.
  • Trinity Biotech's annual revenue for Dec 31, 2023 was $56.83 million, a 9.1% decrease from 2022.
  • Trinity Biotech's annual revenue for 2022 was $62.52 million, a 22.96% decrease from 2021.
  • Trinity Biotech's annual revenue for 2021 was $81.15 million, a 20.43% decrease from 2020.
  • Trinity Biotech's annual revenue for 2020 was $101.98 million, a 12.77% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.